H-L-Aha-OH*HCl

H-L-Aha-OH·HCl is the hydrochloride salt form of an L-amino acid derivative in which the side chain is built from an aliphatic "Aha" motif and the molecule presents the amino acid backbone with a free carboxylic acid and an ion-paired, salt-stabilized amino group. The L-configuration at the alpha stereocenter provides defined stereochemical control for peptide coupling and for stereospecific incorporation into peptide-like frameworks. The presence of the carboxylic acid enables conversion to activated esters or amide-forming derivatives, while the amine functionality can be managed through standard protection/deprotection logic to control chemoselectivity. The hydrochloride counterion improves handling of the amino acid as a chiral intermediate and supports downstream transformations that require reproducible salt-to-free-base equilibria during synthetic work.

1. Protected Amino Acids

H-L-Aha-OH·HCl is commonly positioned in protected amino acid synthesis workflows where the carboxylic acid and amino group are orthogonally protected to enable controlled peptide coupling. The free acid can be converted to an acid-derivative while the amino functionality is typically protected as an amide-compatible N-protecting group, allowing stepwise assembly without side reactions such as undesired salt-driven reactivity. The L-stereocenter remains intact through protection and activation steps, supporting stereochemically defined peptide building block preparation. The resulting protected intermediate can be carried through iterative coupling cycles and later deprotected to regenerate the native amino acid functionality for further derivatization.

2. Peptide Synthesis

H-L-Aha-OH·HCl is suitable for peptide synthesis strategies that require incorporation of a chiral amino acid residue with a defined side-chain topology. The carboxylic acid functionality enables formation of activated coupling partners, while the amino group can be protected to match the coupling chemistry used in solid-phase or solution-phase peptide construction. The Aha side chain can participate in subsequent functional group transformations after peptide assembly, supporting the design of peptide analogs where side-chain chemistry is introduced late in the sequence. The hydrochloride form can be used as a controlled input for converting the amino acid into a peptide-ready protected building block, enabling downstream fragment ligation and sequence diversification.

3. Side-Chain Functionalization

H-L-Aha-OH·HCl supports amino acid derivatization routes where the side-chain "Aha" motif is leveraged as a handle for chemical modification after incorporation or after independent functionalization. The amino acid backbone provides a stable platform for selective activation at the carboxyl group and controlled N-protection, permitting chemoselective transformations that target the side chain rather than the backbone. Side-chain modification can be used to generate functional groups for subsequent conjugation, crosslinking, or incorporation into peptidomimetic scaffolds where steric and stereochemical features influence reactivity and molecular recognition. The resulting derivatives can serve as intermediates for building structure-activity relationship libraries or for preparing defined standards used to track side-chain conversion during synthesis.

4. Chemical Biology Reagents

H-L-Aha-OH·HCl can be applied in chemical biology research as a chiral amino acid precursor for constructing peptide-based probes and biochemical research intermediates. The L-amino acid architecture allows introduction into peptide-like constructs that present backbone amide linkages while retaining a side-chain functional motif for labeling or affinity tuning. Salt handling via the hydrochloride form can improve reproducibility when preparing chiral intermediates for conjugation workflows, including conversion to activated derivatives prior to coupling with biomolecule-reactive partners. Downstream products derived from this amino acid can be used to generate labeled peptides, modified ligands, or probe scaffolds compatible with analytical readouts and biochemical assay development.

5. Pharmaceutical Intermediate Preparation

H-L-Aha-OH·HCl is relevant to pharmaceutical intermediate preparation where chiral amino acid derivatives serve as feedstocks for synthetic routes to peptide-like active ingredients and related small-molecule fragments. The combination of a stereodefined alpha carbon, a carboxylic acid, and an amine that can be protected enables systematic conversion into N-protected, C-activated, or side-chain-modified intermediates used in multi-step manufacturing sequences. The hydrochloride salt form supports controlled material handling and can facilitate reproducible conversion to free-base or activated acid forms during process chemistry. The resulting protected and functionalized derivatives can be used to assemble higher-complexity structures while maintaining stereochemical fidelity through key coupling and deprotection stages.

6. Analytical Research Standards

H-L-Aha-OH·HCl can be used in analytical research as a chiral reference material for method development and characterization of amino acid derivatives and peptide fragments. The defined L-configuration and the presence of the free carboxylic acid enable consistent mass spectrometric and chromatographic behavior when comparing derivatized forms, salt states, or coupling products. The hydrochloride salt provides a practical starting point for preparing labeled or derivatized standards that reflect backbone integrity and side-chain identity. Downstream analytical standards derived from this amino acid can support impurity profiling, stereochemical verification, and confirmation of successful protection/deprotection or coupling in peptide synthesis and related industrial chemical manufacturing workflows.

1. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

2. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

3. The spatiotemporal control of signalling and trafficking of the GLP-1R

4. The effect of B-type allatostatin neuropeptides on crosstalk between the insect immune response and cold tolerance

5. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum